BCL6 attenuates hyperoxia-induced lung injury by inhibiting NLRP3-mediated inflammation in fetal mouse

References

• Thebaud B, Goss KN, Laughon M, et al. Bronchopulmonary dysplasia. Nat Rev Dis Primers. 2019;5(1):78. doi:10.1038/s41572-019-0127-7.
   PubMed Web of Science ®Google Scholar
• Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol. 2003;8(1):73–81. doi:10.1016/s1084-2756(02)00193-8.
   PubMedGoogle Scholar
• Higano NS, Spielberg DR, Fleck RJ, et al. Neonatal pulmonary magnetic resonance imaging of bronchopulmonary dysplasia predicts short-term clinical outcomes. Am J Respir Crit Care Med. 2018;198(10):1302–1311. doi:10.1164/rccm.201711-2287OC.
   PubMed Web of Science ®Google Scholar
• Shahzad T, Radajewski S, Chao CM, Bellusci S, Ehrhardt H. Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development. Mol Cell Pediatr. 2016;3(1):23. doi:10.1186/s40348-016-0051-9.
   PubMedGoogle Scholar
• Broz P, Pelegrin P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2020;20(3):143–157. doi:10.1038/s41577-019-0228-2.
   PubMed Web of Science ®Google Scholar
• Omer M, Melo AM, Kelly L, et al. Emerging role of the NLRP3 inflammasome and interleukin-1beta in neonates. Neonatology. 2020;117(5):545–554. doi:10.1159/000507584.
   PubMed Web of Science ®Google Scholar
• Coll RC, Schroder K, Pelegrin P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci. 2022;43(8):653–668. doi:10.1016/j.tips.2022.04.003.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ran X, He Y, Ai Q, Shi Y. Acetate down regulates the activation of NLRP3 inflammasomes and attenuates lung injury in neonatal mice with bronchopulmonary dysplasia. Front Pediatr. 2020;8:595157. doi:10.3389/fped.2020.595157.
   PubMed Web of Science ®Google Scholar
• Liao J, Kapadia VS, Brown LS, et al. The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia. Nat Commun. 2015;6(1):8977. doi:10.1038/ncomms9977.
   PubMedGoogle Scholar
• Stouch AN, McCoy AM, Greer RM, et al. IL-1beta and inflammasome activity link inflammation to abnormal fetal airway development. J Immunol. 2016;196(8):3411–3420. doi:10.4049/jimmunol.1500906.
   PubMed Web of Science ®Google Scholar
• Dong L, He Y, Cao Y, et al. Functional differentiation and regulation of follicular T helper cells in inflammation and autoimmunity. Immunology. 2021;163(1):19–32. doi:10.1111/imm.13282.
   PubMed Web of Science ®Google Scholar
• Kurosu T, Fukuda T, Miki T, Miura O. BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells. Oncogene. 2003;22(29):4459–4468. doi:10.1038/sj.onc.1206755.
   PubMed Web of Science ®Google Scholar
• Chen D, Xiong XQ, Zang YH, et al. BCL6 attenuates renal inflammation via negative regulation of NLRP3 transcription. Cell Death Dis. 2017;8(10):e3156–e3156. doi:10.1038/cddis.2017.567.
   PubMedGoogle Scholar
• Zhang S, Lin S, Tang Q, Yan Z. Knockdown of miR2055p alleviates the inflammatory response in allergic rhinitis by targeting B cell lymphoma 6. Mol Med Rep. 2021;24(5):1–11 doi:10.3892/mmr.2021.12458.
   Web of Science ®Google Scholar
• Sun Y, Chen C, Di T, et al. Human beta-defensin-2 improves hyperoxia-induced lung structural and functional injury in neonatal rats. Med Sci Monit. 2019;25:6074–6084. doi:10.12659/MSM.915814.
   PubMed Web of Science ®Google Scholar
• Durrani-Kolarik S, Pool CA, Gray A, et al. miR-29b supplementation decreases expression of matrix proteins and improves alveolarization in mice exposed to maternal inflammation and neonatal hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2017;313(2):L339–L349. doi:10.1152/ajplung.00273.2016.
   PubMed Web of Science ®Google Scholar
• Sureshbabu A, Syed M, Das P, et al. Inhibition of regulatory-associated protein of mechanistic target of rapamycin prevents hyperoxia-induced lung injury by enhancing autophagy and reducing apoptosis in neonatal mice. Am J Respir Cell Mol Biol. 2016;55(5):722–735. doi:10.1165/rcmb.2015-0349OC.
   PubMed Web of Science ®Google Scholar
• Willis GR, Fernandez-Gonzalez A, Reis M, et al. Mesenchymal stromal cell-derived small extracellular vesicles restore lung architecture and improve exercise capacity in a model of neonatal hyperoxia-induced lung injury. J Extracell Vesicles. 2020;9(1):1790874. doi:10.1080/20013078.2020.1790874.
   PubMed Web of Science ®Google Scholar
• Cardenas MG, Yu WB, Beguelin W, et al. Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma. J Clin Invest. 2016;126(9):3351–3362. doi:10.1172/Jci85795.
   PubMed Web of Science ®Google Scholar
• Chen D, Gao ZQ, Wang YY, et al. Sodium propionate enhances Nrf2-mediated protective defense against oxidative stress and inflammation in lipopolysaccharide-induced neonatal Mice. J Inflamm Res. 2021;14:803–816. doi:10.2147/JIR.S303105.
   PubMed Web of Science ®Google Scholar
• Hu Y, Sun X, Wang S, et al. Toll-like receptor-2 gene knockout results in neurobehavioral dysfunctions and multiple brain structural and functional abnormalities in mice. Brain Behav Immun. 2021;91:257–266. doi:10.1016/j.bbi.2020.10.004.
   PubMed Web of Science ®Google Scholar
• Wang C, Xu K, Wang Y, et al. Spinal cannabinoid receptor 2 activation reduces hypersensitivity associated with bone cancer pain and improves the integrity of the blood-spinal cord barrier. Reg Anesth Pain Med. 2020;45(10):783–791. doi:10.1136/rapm-2019-101262.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Coarfa C, Dong X, et al. MicroRNA-30a as a candidate underlying sex-specific differences in neonatal hyperoxic lung injury: implications for BPD. Am J Physiol Lung Cell Mol Physiol. 2019;316(1):L144–L156. doi:10.1152/ajplung.00372.2018.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dong X, Shirazi J, Gleghorn JP, Lingappan K. Pulmonary endothelial cells exhibit sexual dimorphism in their response to hyperoxia. Am J Physiol Heart Circ Physiol. 2018;315(5):H1287–H1292. doi:10.1152/ajpheart.00416.2018.
   PubMed Web of Science ®Google Scholar
• Chen D, Wu YX, Qiu YB, et al. Hyperoside suppresses hypoxia-induced A549 survival and proliferation through ferrous accumulation via AMPK/HO-1 axis. Phytomedicine. 2020;67:153138. doi:10.1016/j.phymed.2019.153138.
   PubMed Web of Science ®Google Scholar
• Thebaud B, Ladha F, Michelakis ED, et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation. 2005;112(16):2477–2486. doi:10.1161/CIRCULATIONAHA.105.541524.
   PubMed Web of Science ®Google Scholar
• Wu JB, Tang YL, Liang XH. Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy. Onco Targets Ther. 2018;11:6901–6909. doi:10.2147/OTT.S172042.
   PubMed Web of Science ®Google Scholar
• Pitulescu ME, Schmidt I, Giaimo BD, et al. Dll4 and Notch signalling couples sprouting angiogenesis and artery formation. Nat Cell Biol. 2017;19(8):915–927. doi:10.1038/ncb3555.
   PubMed Web of Science ®Google Scholar
• Testini C, Smith RO, Jin Y, et al. Myc-dependent endothelial proliferation is controlled by phosphotyrosine 1212 in VEGF receptor-2. EMBO Rep. 2019;20(11):e47845. doi:10.15252/embr.201947845.
   PubMed Web of Science ®Google Scholar
• Li X, Redfors B, Sainz-Jaspeado M, et al. Suppressed vascular leakage and myocardial edema improve outcome from myocardial infarction. Front Physiol. 2020;11:763. doi:10.3389/fphys.2020.00763.
   PubMed Web of Science ®Google Scholar
• Giusto K, Wanczyk H, Jensen T, Finck C. Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies. Dis Model Mech. 2021;14(2):dmm047753. doi:10.1242/dmm.047753.
   PubMed Web of Science ®Google Scholar
• Nardiello C, Mizikova I, Silva DM, et al. Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia. Dis Model Mech. 2017;10(2):185–196. doi:10.1242/dmm.027086.
   PubMed Web of Science ®Google Scholar
• Royce SG, Nold MF, Bui C, et al. Airway remodeling and hyperreactivity in a model of bronchopulmonary dysplasia and their modulation by IL-1 receptor antagonist. Am J Respir Cell Mol Biol. 2016;55(6):858–868. doi:10.1165/rcmb.2016-0031OC.
   PubMed Web of Science ®Google Scholar
• Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012;481(7381):278–286. doi:10.1038/nature10759.
   PubMed Web of Science ®Google Scholar
• Chen X, He WT, Hu L, et al. Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res. 2016;26(9):1007–1020. doi:10.1038/cr.2016.100.
   PubMed Web of Science ®Google Scholar
• Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660–665. doi:10.1038/nature15514.
   PubMed Web of Science ®Google Scholar
• Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42(4):245–254. doi:10.1016/j.tibs.2016.10.004.
   PubMed Web of Science ®Google Scholar
• Dapaah-Siakwan F, Zambrano R, Luo S, et al. Caspase-1 inhibition attenuates hyperoxia-induced lung and brain injury in neonatal mice. Am J Respir Cell Mol Biol. 2019;61(3):341–354. doi:10.1165/rcmb.2018-0192OC.
   PubMed Web of Science ®Google Scholar
• Rout-Pitt N, Farrow N, Parsons D, Donnelley M. Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology. Respir Res. 2018;19(1):136. doi:10.1186/s12931-018-0834-8.
   PubMedGoogle Scholar
• Scanlon CS, Van Tubergen EA, Inglehart RC, D’Silva NJ. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res. 2013;92(2):114–121. doi:10.1177/0022034512467352.
   PubMed Web of Science ®Google Scholar
• Pardo A, Selman M. Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc. 2006;3(4):383–388. doi:10.1513/pats.200601-012TK.
   PubMedGoogle Scholar
• Rockey DC, Bell PD, Hill JA. Fibrosis–a common pathway to organ injury and failure. N Engl J Med. 2015;372(12):1138–1149. doi:10.1056/NEJMra1300575.
   PubMed Web of Science ®Google Scholar
• Wuyts WA, Agostini C, Antoniou KM, et al. The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J. 2013;41(5):1207–1218. doi:10.1183/09031936.00073012.
   PubMed Web of Science ®Google Scholar
• Hewlett JC, Kropski JA, Blackwell TS. Idiopathic pulmonary fibrosis: epithelial-mesenchymal interactions and emerging therapeutic targets. Matrix Biol. 2018;71-72:112–127. doi:10.1016/j.matbio.2018.03.021.
   PubMed Web of Science ®Google Scholar
• Brody AR. Occupational lung disease and the role of peptide growth factors. Curr Opin Pulm Med. 1997;3(3):203–208. doi:10.1097/00063198-199705000-00004.
   PubMedGoogle Scholar
• Toti P, Buonocore G, Tanganelli P, et al. Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study. Pediatr Pulmonol. 1997;24(1):22–28. doi:10.1002/(sici)1099-0496(199707)24:1<22::aid-ppul4>3.0.co;2-l.
   PubMed Web of Science ®Google Scholar
• Sinkin RA, Roberts M, LoMonaco MB, Sanders RJ, Metlay LA. Fibronectin expression in bronchopulmonary dysplasia. Pediatr Dev Pathol. 1998;1(6):494–502. doi:10.1007/s100249900068.
   PubMed Web of Science ®Google Scholar
• McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med. 2001;164(10 Pt 2):S39–S45. doi:10.1164/ajrccm.164.supplement_2.2106065.
   PubMed Web of Science ®Google Scholar
• Crapo JD, Barry BE, Foscue HA, Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis. 1980;122(1):123–143. doi:10.1164/arrd.1980.122.1.123.
   PubMedGoogle Scholar
• Perkett EA, Klekamp JG. Vascular endothelial growth factor expression is decreased in rat lung following exposure to 24 or 48 hours of hyperoxia: implications for endothelial cell survival. Chest. 1998;114(1 Suppl):52S–53S. doi:10.1378/chest.114.1_supplement.52s.
   PubMed Web of Science ®Google Scholar
• You K, Xu X, Fu J, et al. Hyperoxia disrupts pulmonary epithelial barrier in newborn rats via the deterioration of occludin and ZO-1. Respir Res. 2012;13(1):36. doi:10.1186/1465-9921-13-36.
   PubMedGoogle Scholar
• Campochiaro PA. Molecular pathogenesis of retinal and choroidal vascular diseases. Prog Retin Eye Res. 2015;49:67–81. doi:10.1016/j.preteyeres.2015.06.002.
   PubMed Web of Science ®Google Scholar
• Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364(7):603–615. doi:10.1056/NEJMoa1007374.
   PubMed Web of Science ®Google Scholar
• Yu X, Lin Q, Qin X, et al. ACE2 antagonizes VEGFa to reduce vascular permeability during acute lung injury. Cell Physiol Biochem. 2016;38(3):1055–1062. doi:10.1159/000443056.
   PubMedGoogle Scholar